1. Home
  2. CSBR vs ONCY Comparison

CSBR vs ONCY Comparison

Compare CSBR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

HOLD

Current Price

$6.34

Market Cap

82.7M

Sector

Health Care

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.99

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSBR
ONCY
Founded
1985
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.7M
94.0M
IPO Year
2015
2002

Fundamental Metrics

Financial Performance
Metric
CSBR
ONCY
Price
$6.34
$0.99
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
5.7K
1.1M
Earning Date
06-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
161.11
N/A
EPS
N/A
N/A
Revenue
$2,900,000.00
N/A
Revenue This Year
$4.84
N/A
Revenue Next Year
$11.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.50
$0.33
52 Week High
$10.25
$1.51

Technical Indicators

Market Signals
Indicator
CSBR
ONCY
Relative Strength Index (RSI) 50.42 47.79
Support Level $6.11 $0.94
Resistance Level $6.24 $1.08
Average True Range (ATR) 0.21 0.07
MACD 0.06 -0.01
Stochastic Oscillator 78.75 22.65

Price Performance

Historical Comparison
CSBR
ONCY

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: